应对胰腺癌关键挑战的新策略
Novel Strategies to Address Critical Challenges in Pancreatic Cancer.
作者信息
Puik Jisce R, Swijnenburg Rutger-Jan, Kazemier Geert, Giovannetti Elisa
机构信息
Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands.
出版信息
Cancers (Basel). 2022 Aug 25;14(17):4115. doi: 10.3390/cancers14174115.
Abstract
Whereas mortality rates improved for breast and prostate cancer as a result of successful tumour biology-based therapies and biomarkers, mortality rates for pancreatic cancer patients remained stable [...].
摘要
鉴于基于肿瘤生物学的成功疗法和生物标志物使乳腺癌和前列腺癌的死亡率有所改善，而胰腺癌患者的死亡率仍保持稳定[...]。
相似文献
1
Novel Strategies to Address Critical Challenges in Pancreatic Cancer.应对胰腺癌关键挑战的新策略
Cancers (Basel). 2022 Aug 25;14(17):4115. doi: 10.3390/cancers14174115.
2
Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.接受手术探查但未行切除术的胰腺癌患者的全国性结局。
Br J Surg. 2017 Oct;104(11):1568-1577. doi: 10.1002/bjs.10602. Epub 2017 Aug 22.
3
What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?在1型多发性内分泌腺瘤成年患者筛查中发现的无功能胰腺神经内分泌肿瘤，合适的管理措施是什么？
Clin Endocrinol (Oxf). 2019 Dec;91(6):708-715. doi: 10.1111/cen.14094. Epub 2019 Oct 1.
4
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).转移性胰腺腺癌患者中吉西他滨联合奥沙利铂的 II 期临床试验，这些患者有胰腺/乳腺/卵巢/前列腺癌家族史或有乳腺癌/卵巢癌/前列腺癌个人史（FABRIC 研究）。
Int J Clin Oncol. 2020 Oct;25(10):1835-1843. doi: 10.1007/s10147-020-01721-x. Epub 2020 Jun 13.
5
Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets.胰腺癌中的癌相关成纤维细胞：新亚型、新标志物、新靶点。
J Pathol. 2022 Jul;257(4):526-544. doi: 10.1002/path.5926. Epub 2022 Jun 7.
6
Pancreatic cancer organotypic cultures.胰腺癌器官型培养物。
J Biotechnol. 2010 Jul 1;148(1):16-23. doi: 10.1016/j.jbiotec.2010.01.008. Epub 2010 Jan 18.
7
The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities.胰腺神经内分泌肿瘤的分子生物学：挑战与转化机会。
Semin Cancer Biol. 2020 Apr;61:132-138. doi: 10.1016/j.semcancer.2019.09.024. Epub 2019 Sep 29.
8
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.目前和新兴的治疗方法为晚期胰腺导管腺癌患者带来希望。
Lancet Oncol. 2020 Mar;21(3):e135-e145. doi: 10.1016/S1470-2045(19)30795-8.
9
Evolution of novel therapeutic options for pancreatic cancer.胰腺癌新型治疗方案的进展
Curr Opin Gastroenterol. 2016 Sep;32(5):401-407. doi: 10.1097/MOG.0000000000000298.
10
[A Novel Treatment Strategy for Pancreatic Cancer Based on Gene Profiles].基于基因图谱的胰腺癌新型治疗策略
Gan To Kagaku Ryoho. 2016 Nov;43(11):1326-1331.
引用本文的文献
1
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells.通过基因扩增过表达 ABCB1 是克服胰腺癌紫杉醇耐药的一个可行靶点。
J Exp Clin Cancer Res. 2024 Jan 2;43(1):4. doi: 10.1186/s13046-023-02879-8.
2
Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.胰腺腺癌中细胞焦亡相关预后特征的解析及 CASP6 介导的调控作用：为临床决策提供新视角。
Apoptosis. 2023 Jun;28(5-6):769-782. doi: 10.1007/s10495-023-01823-7. Epub 2023 Mar 7.
本文引用的文献
1
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer.靶向前列腺特异性膜抗原（PSMA）彻底改变了核医学在前列腺癌诊断和治疗中的作用。
Cancers (Basel). 2022 Feb 24;14(5):1169. doi: 10.3390/cancers14051169.
2
Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment.胰腺癌治疗的当前局限与新视角
Cancers (Basel). 2022 Feb 16;14(4):985. doi: 10.3390/cancers14040985.
3
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach.CA19-9与胆红素比值在胰腺癌、远端胆管癌及壶腹周围良性疾病患者中的诊断价值：一种新方法
Cancers (Basel). 2022 Jan 11;14(2):344. doi: 10.3390/cancers14020344.
4
Cancer statistics, 2022.癌症统计数据，2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
5
CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target.胰腺癌中的CXCL12：其功能及作为治疗药物靶点的潜力
Cancers (Basel). 2021 Dec 24;14(1):86. doi: 10.3390/cancers14010086.
6
Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights.微流控辅助制备靶向pH响应性聚合物胶束可提高吉西他滨在胰腺癌中的疗效：体外研究见解
Cancers (Basel). 2021 Dec 21;14(1):5. doi: 10.3390/cancers14010005.
7
Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌的分子靶向正电子发射断层显像与放射性核素治疗
Cancers (Basel). 2021 Dec 7;13(24):6164. doi: 10.3390/cancers13246164.
8
The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell Tumorigenesis.黏蛋白4癌蛋白的表皮生长因子结构域介导HER2结合亲和力并促进胰腺癌细胞肿瘤发生。
Cancers (Basel). 2021 Nov 16;13(22):5746. doi: 10.3390/cancers13225746.
9
Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance.上皮-间质转化：胰腺导管腺癌进展和化疗耐药的关键调节因子
Cancers (Basel). 2021 Nov 4;13(21):5532. doi: 10.3390/cancers13215532.
10
Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC).细胞周期蛋白依赖性激酶-1（CDK-1）抑制作为一种针对胰腺导管腺癌（PDAC）的新型治疗策略。
Cancers (Basel). 2021 Aug 30;13(17):4389. doi: 10.3390/cancers13174389.
Zotero 插件